06/02/2023
Published by Fondazione Gianni Bonadonna at 06/02/2023
Categories

Federated learning to predicting chemotherapy response in triple-negative breast cancer

Do you like it?0
Read more
30/01/2023
Published by Fondazione Gianni Bonadonna at 30/01/2023
Categories

Clinical benefits with futibatinib in intra-hepatic cholangiocarcinoma

Do you like it?0
Read more
23/01/2023
Published by Fondazione Gianni Bonadonna at 23/01/2023
Categories

PARP inhibitors in advanced prostate cancer, determining HRR genes alterations is crucial for outcomes

Do you like it?0
Read more
16/01/2023
Published by Fondazione Gianni Bonadonna at 16/01/2023
Categories

Promising results with lurbinectedin in relapsed Ewing sarcoma

Do you like it?0
Read more
09/01/2023
Published by Fondazione Gianni Bonadonna at 09/01/2023
Categories

Trastuzumab deruxtecan in HER2+ metastatic breast cancer

Do you like it?0
Read more
02/01/2023
Published by Fondazione Gianni Bonadonna at 02/01/2023
Categories

SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma

Do you like it?0
Read more
19/12/2022
Published by Fondazione Gianni Bonadonna at 19/12/2022
Categories

The bispecific antibody zanidatamab in HER2 expressing solid tumors

Do you like it?0
Read more
12/12/2022
Published by Fondazione Gianni Bonadonna at 12/12/2022
Categories

Fondazione Michelangelo at the San Antonio Breast Cancer Symposium

Do you like it?0
Read more
05/12/2022
Published by Fondazione Gianni Bonadonna at 05/12/2022
Categories

Combination of olaparib and radiotherapy in triple-negative breast cancer

Do you like it?0
Read more
12345678910
Next page